The Role of Schedule of Antibiotic Therapy on the Neutropenic Patient
Overview
Authors
Affiliations
van den Berg J, Fontijne P, Michel M Eur J Clin Microbiol. 1984; 3(2):131-5.
PMID: 6723636 DOI: 10.1007/BF02014330.
Clinical pharmacology of moxalactam in patients with malignant disease.
Estey E, Weaver S, Ho D, Bodey G Antimicrob Agents Chemother. 1981; 19(4):639-44.
PMID: 6454389 PMC: 181493. DOI: 10.1128/AAC.19.4.639.
Multiple-dose pharmacokinetics of ceftazidime in cancer patients.
Garcia I, Fainstein V, Smith R, Bodey G Antimicrob Agents Chemother. 1983; 24(2):141-4.
PMID: 6357067 PMC: 185126. DOI: 10.1128/AAC.24.2.141.
Clinical pharmacology of ceftriaxone in patients with neoplastic disease.
Salvador P, Smith R, Weinfeld R, Ellis D, Bodey G Antimicrob Agents Chemother. 1983; 23(4):583-8.
PMID: 6305263 PMC: 184705. DOI: 10.1128/AAC.23.4.583.
Blaser J, Stone B, Zinner S Antimicrob Agents Chemother. 1985; 27(3):343-9.
PMID: 3922294 PMC: 176274. DOI: 10.1128/AAC.27.3.343.